Company / R&D per Share
Intellia Therapeutics, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.81
FY2025
5-year range
$3.47 / $5.64
FY2021-FY2025
Trend
-24.0%
vs FY2024
Sector context
#13 of 103
Health Care
What the data says
Intellia Therapeutics, Inc.'s r&d per share of $3.81 is higher than 87% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 10 years, ranging from $1.43 in FY2016 to $5.64 in FY2022.
Based on SEC 10-K filings.
3.81 in FY2025 with a 5-year CAGR of +4.9%. Top quartile in the Health Care sector.
Declined from $4.99 to $3.81 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -12.2%
- 5-Year CAGR
- +4.9%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 103This company $3.81 Sector average $2.13
▼
+78.7% above sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 24.0% year-over-year.
- Ranks #13 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.81 | -24.0% |
| FY2024 | $5.01 | +0.4% |
| FY2023 | $4.99 | -11.4% |
| FY2022 | $5.64 | +62.5% |
| FY2021 | $3.47 | +15.8% |
| FY2020 | $3.00 | +25.0% |
| FY2019 | $2.40 | +14.0% |
| FY2018 | $2.10 | +11.9% |
| FY2017 | $1.88 | +31.1% |
| FY2016 | $1.43 | -96.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026